PaxMedica (MEX:PXMD) Payments of Debt: MXN5.38 Mil (TTM As of Sep. 2024)


MEX:PXMD PaxMedica Inc MEX:PXMD
20 GF Score
Price MXN15.69
View Full Analysis

What is PaxMedica Payments of Debt?

PaxMedica MEX:PXMD 20 Payments of Debt is MXN5.38 Mil as of Sep. 2024. GuruFocus rates MEX:PXMD with a GF Score™ of 20/100.

PaxMedica's Payments of Debt for the three months ended in Sep. 2024 was MXN0.00 Mil.

PaxMedica's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was MXN5.38 Mil.

PaxMedica Payments of Debt Related Terms

PaxMedica Payments of Debt Historical Data

* Premium members only.

The historical data trend for PaxMedica's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PaxMedica Payments of Debt Chart

PaxMedica Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Payments of Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -12.66

PaxMedica Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.61 5.38 0.00 0.00 0.00
MEX:PXMD
20GF Score
PaxMedica Inc MEX:PXMD
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PaxMedica Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of MXN5.38 Mil mean?
PaxMedica (MEX:PXMD) has a Payments of Debt of MXN5.38 Mil as of Sep. 2024. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on PaxMedica and its competitors.
Is PaxMedica's Payments of Debt too high?
PaxMedica's current Payments of Debt is MXN5.38 Mil. Overall, PaxMedica has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does PaxMedica's Payments of Debt compare to BTAX and NBIO?
PaxMedica's Payments of Debt of MXN5.38 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on PaxMedica and its competitors. PaxMedica's current Payments of Debt is MXN5.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PaxMedica stock overvalued right now?
PaxMedica (MEX:PXMD) has a current Payments of Debt of MXN5.38 Mil. The current Payments of Debt is MXN5.38 Mil. PaxMedica's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For PaxMedica (MEX:PXMD), the current Payments of Debt is MXN5.38 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PaxMedica Business Description

Address 303 South Broadway, Suite 125, Tarrytown, NJ, USA, 10591
PaxMedica Inc is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (COVID-19). The company's product candidate under development is PAX-101, an intravenous formulation of suramin, which it is developing for multiple indications, including East African HAT, ASD, ME/CFS, and LCS.
20GF Score

Get the complete analysis for MEX:PXMD

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN15.69
Price